Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Sulfate Solution vs Polyethylene Glycol for Bowel Preparation in IBD
ChiCTR2600130743Phase 4Completed
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of magnesium sulfate, sodium sulfate, potassium sulfate and macrogol 4000 in inflammatory bowel disease (IBD), autoimmune colitis and Crohn's disease (2 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoint: Success rate of bowel preparation. Started Aug 2026; status: completed.
02
Drugs
magnesium sulfatesodium sulfatepotassium sulfatemacrogol 4000
03
Conditions
inflammatory bowel disease (IBD)autoimmune colitisCrohn's disease
Beyond the preview
Go deeper on ChiCTR2600130743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600130743.